JNJ logo

JOHNSON & JOHNSON

JNJNYSE
πŸ† #21 by market capEarnings Jan 20 Β· PreUS Equity
$270.47β–² $3.34 (+1.25%)
Market closed Β· at close
πŸ””
Track JNJ
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.3%
7dβ–Ό 5.4%
14dβ–Ό 2.1%
30dβ–² 2.5%
ytdβ–² 30.7%
1yβ–² 32.5%
🏦Market Cap
$651.11B
Large Cap
πŸ“ˆRevenue Growth (YoY)
7.8%
Slowing
πŸ“ŠGross Margin
67.7%
High
πŸ’΅FCF Margin
20.7%
Strong
βš–οΈP/S Ratio
6.6x
Fair
Otter Score
72
Strong

Trading Snapshot

Day Range
$269.47 – $272.48
52-Week Range
$199.38 – $290.25
Volume (shares)
11,918,787
Avg Volume (shares)
β€”
Shares Outstanding
2.41B
Next Earnings
2027-01-20

Fundamentals Snapshot

Annual Revenue
$94.19B
Last Q Revenue
$25.40B
P/E Ratio
40.7
P/S Ratio
6.6x
EPS (TTM)
$6.59
Dividend Yield
1.94%
Dilution (1yr)
+0.5%
JNJ logo

JOHNSON & JOHNSON

JNJ
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$94.2Bβ–² +6.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
67.9%β–Ό βˆ’1.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$25.6Bβ–² +15.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$19.7Bβ–Ό βˆ’0.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2.44Bβ–² +0.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$28.2Bβ–Ό βˆ’$15.7B YoY
StockOtter Β· stockotter.space

About JOHNSON & JOHNSON

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100
Analyst data unavailable.

Latest News & Updates

24/7 Wall StreetΒ·9h ago

The Dividend Investing Strategy That Made Geraldine Weiss a Wall Street Legend

Brokerage firms turned Weiss away when she tried to become an analyst. In 1966 she co-founded Investment Quality Trends and became the first woman to start an investment advisory service.

The Motley FoolΒ·11h ago

Johnson & Johnson Is on Track for $101 Billion in 2026 Sales. Is This Dividend King Still a Buy?

Johnson & Johnson is a leader in the pharmaceutical and medical device sectors. JNJ is a Dividend King with an above-market yield.

The Motley FoolΒ·11h ago

Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

Johnson & Johnson maintains a diversified business model balancing pharmaceutical innovation with a massive medical technology segment. Pfizer is undergoing a significant transition by investing heavily in oncology and o

24/7 Wall StreetΒ·1d ago

3 Reasons Dividend Aristocrats Belong in Your Roth IRA Before You Retire

At the 24% bracket, a $500,000 equal-weight position in three Dividend Aristocrats returns about $10,933 a year in dividends. In a taxable account, roughly $1,640 of that goes to the IRS every year at the 15% qualified r

BenzingaΒ·1d ago

Benzinga's 'Stock Whisper' Index: Five Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week,Β Benzinga's Stock Whisper IndexΒ uses proprietary data and pattern recognition to highlight five stocks just under the surface that deserve attention.

24/7 Wall StreetΒ·1d ago

5 Dividend Kings to Buy for Lifelong Income Before the End of November

Yield chasers keep learning the same lesson: A payout is only as durable as the cash flow behind it.